{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:20:58Z","timestamp":1793146858696,"version":"4.5.0"},"reference-count":120,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T00:00:00Z","timestamp":1726704000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.fertnstert.2024.09.023","type":"journal-article","created":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T20:02:37Z","timestamp":1731528157000},"page":"506-519","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["An umbrella review of meta-analyses regarding the incidence of female-specific malignancies after fertility treatment"],"prefix":"10.1016","volume":"123","author":[{"given":"Srdjan","family":"Saso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jen F.","family":"Barcroft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorraine S.","family":"Kasaven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Galazis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2840-9572","authenticated-orcid":false,"given":"Br\u00edd","family":"N\u00ed Dhonnabh\u00e1in","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen J.","family":"Grewal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Bracewell-Milnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin P.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Getreu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxine","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Mitra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maya","family":"Al-Memar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jara","family":"Ben-Nagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Richard","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Yazbek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Timmerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Bourne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadaf","family":"Ghaem-Maghami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan Y.","family":"Verbakel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2024.09.023_bib1","doi-asserted-by":"crossref","first-page":"e1001356","DOI":"10.1371\/journal.pmed.1001356","article-title":"National, regional, and global trends in infertility prevalence since 1990: a systematic analysis of 277 health surveys","volume":"9","author":"Mascarenhas","year":"2012","journal-title":"PLoS Med"},{"key":"10.1016\/j.fertnstert.2024.09.023_bib2","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/humupd\/dmr040","article-title":"Demographic and medical consequences of the postponement of parenthood","volume":"18","author":"Schmidt","year":"2012","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2024.09.023_bib3","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1054\/bjoc.2000.1596","article-title":"Menstrual and reproductive factors in relation to ovarian cancer risk","volume":"84","author":"Titus-Ernstoff","year":"2001","journal-title":"Br J Cancer"},{"key":"10.1016\/j.fertnstert.2024.09.023_bib4","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S0140-6736(79)91435-1","article-title":"\u2018Incessant ovulation\u2019 and ovarian cancer","volume":"2","author":"Casagrande","year":"1979","journal-title":"Lancet"},{"key":"10.1016\/j.fertnstert.2024.09.023_bib5","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1093\/jnci\/90.23.1774","article-title":"Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone","volume":"90","author":"Risch","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.fertnstert.2024.09.023_bib6","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1093\/humupd\/2.1.63","article-title":"The link between female infertility and cancer: epidemiology and possible aetiologies","volume":"2","author":"Meirow","year":"1996","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2024.09.023_bib7","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/PAS.0b013e3181cf3d79","article-title":"The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory","volume":"34","author":"Kurman","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.fertnstert.2024.09.023_bib8","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.gyobfe.2009.06.007","article-title":"Risques de la stimulation ovarienne et du pr\u00e9l\u00e8vement ovocytaire [Ovarian stimulation and follicular puncture risks]","volume":"37","author":"Merviel","year":"2009","journal-title":"Gynceol Obstet Fertil"},{"key":"10.1016\/j.fertnstert.2024.09.023_bib9","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1038\/sj.bjc.6601764","article-title":"Comparison of risk factors for squamous cell and adenocarcinomas of the cervix: a meta-analysis","volume":"90","author":"Berrington de Gonz\u00e1lez","year":"2004","journal-title":"Br J Cancer"},{"key":"10.1016\/j.fertnstert.2024.09.023_bib10","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/GCO.0000000000000370","article-title":"Use of fertility medications and cancer risk: a review and update","volume":"29","author":"Kroener","year":"2017","journal-title":"Curr Opin Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2024.09.023_bib11","first-page":"299","article-title":"Does fertility treatment increase the risk of breast cancer? Current knowledge and meta-analysis","volume":"45","author":"Gabriele","year":"2017","journal-title":"Gynecol Obstet Fertil Senol"},{"key":"10.1016\/j.fertnstert.2024.09.023_bib12","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1093\/humupd\/dmu012","article-title":"Risk of endometrial, ovarian and breast cancer in women with polycystic ovary syndrome: a systematic review and meta-analysis","volume":"20","author":"Barry","year":"2014","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2024.09.023_bib13","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1097\/01.AOG.0000119226.39514.1d","article-title":"Assisted reproductive technology and the incidence of ovarian cancer: a meta-analysis","volume":"103","author":"Kashyap","year":"2004","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2024.09.023_bib14","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/ijc.11141","article-title":"Meta-analysis of social inequality and the risk of cervical cancer","volume":"105","author":"Parikh","year":"2003","journal-title":"Int J Cancer"},{"key":"10.1016\/j.fertnstert.2024.09.023_bib15","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ejogrb.2015.09.002","article-title":"Does fertility treatment increase the risk of uterine cancer? A meta-analysis","volume":"195","author":"Saso","year":"2015","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.fertnstert.2024.09.023_bib16","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1093\/humupd\/dmt034","article-title":"IVF and breast cancer: a systematic review and meta-analysis","volume":"20","author":"Sergentanis","year":"2014","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2024.09.023_bib17","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/humupd\/dms051","article-title":"Controlled ovarian hyperstimulation for IVF: impact on ovarian, endometrial and cervical cancer\u2014a systematic review and meta-analysis","volume":"19","author":"Siristatidis","year":"2013","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2024.09.023_bib18","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group","volume":"283","author":"Stroup","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.fertnstert.2024.09.023_bib19","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/S1470-2045(12)70425-4","article-title":"Menarche, menopause, and breast cancer risk: individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies","volume":"13","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.fertnstert.2024.09.023_bib20","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1002\/ijc.22717","article-title":"Diabetes mellitus and risk of breast cancer: a meta-analysis","volume":"121","author":"Larsson","year":"2007","journal-title":"Int J Cancer"},{"key":"10.1016\/j.fertnstert.2024.09.023_bib21","series-title":"Monographs in epidemiology and biostatistics. Textbook of cancer epidemiology","first-page":"748","year":"2008"},{"key":"10.1016\/j.fertnstert.2024.09.023_bib22","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"key":"10.1016\/j.fertnstert.2024.09.023_bib23","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"Br Med J"},{"key":"10.1016\/j.fertnstert.2024.09.023_bib24","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1136\/bmj.39343.408449.80","article-title":"Uncertainty in heterogeneity estimates in meta-analyses","volume":"335","author":"Ioannidis","year":"2007","journal-title":"Br Med J"},{"key":"10.1016\/j.fertnstert.2024.09.023_bib25","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1002\/(SICI)1097-0258(19980430)17:8<841::AID-SIM781>3.0.CO;2-D","article-title":"Detecting and describing heterogeneity in meta-analysis","volume":"17","author":"Hardy","year":"1998","journal-title":"Stat Med"},{"key":"10.1016\/j.fertnstert.2024.09.023_bib26","doi-asserted-by":"crossref","first-page":"d549","DOI":"10.1136\/bmj.d549","article-title":"Interpretation of random effects meta-analyses","volume":"342","author":"Riley","year":"2011","journal-title":"Br Med J"},{"key":"10.1016\/j.fertnstert.2024.09.023_bib27","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1467-985X.2008.00552.x","article-title":"A re-evaluation of random-effects meta-analysis","volume":"172","author":"Higgins","year":"2009","journal-title":"J R Stat Soc Ser A Stat Soc"},{"key":"10.1016\/j.fertnstert.2024.09.023_bib28","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"Br Med J"},{"key":"10.1016\/j.fertnstert.2024.09.023_bib29","doi-asserted-by":"crossref","first-page":"d4002","DOI":"10.1136\/bmj.d4002","article-title":"Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials","volume":"343","author":"Sterne","year":"2011","journal-title":"Br Med J"},{"key":"10.1016\/j.fertnstert.2024.09.023_bib30","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1471-2288-9-2","article-title":"Assessment of regression-based methods to adjust for publication bias through a comprehensive simulation study","volume":"9","author":"Moreno","year":"2009","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.fertnstert.2024.09.023_bib31","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1093\/biostatistics\/kxq046","article-title":"Treatment-effect estimates adjusted for small-study effects via a limit meta-analysis","volume":"12","author":"R\u00fccker","year":"2011","journal-title":"Biostatistics"},{"key":"10.1016\/j.fertnstert.2024.09.023_bib32","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1177\/1740774507079441","article-title":"An exploratory test for an excess of significant findings","volume":"4","author":"Ioannidis","year":"2007","journal-title":"Clin Trials"},{"key":"10.1016\/j.fertnstert.2024.09.023_bib33","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1093\/jnci\/djs437","article-title":"Evaluation of excess statistical significance in meta-analyses of 98 biomarker associations with cancer risk","volume":"104","author":"Tsilidis","year":"2012","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.fertnstert.2024.09.023_bib34","doi-asserted-by":"crossref","first-page":"j4008","DOI":"10.1136\/bmj.j4008","article-title":"AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both","volume":"358","author":"Shea","year":"2017","journal-title":"Br Med J"},{"key":"10.1016\/j.fertnstert.2024.09.023_bib35","doi-asserted-by":"crossref","first-page":"g7607","DOI":"10.1136\/bmj.g7607","article-title":"Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies","volume":"350","author":"Tsilidis","year":"2015","journal-title":"Br Med J"},{"key":"10.1016\/j.fertnstert.2024.09.023_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.parkreldis.2015.12.008","article-title":"Environmental risk factors and Parkinson\u2019s disease: an umbrella review of meta-analyses","volume":"23","author":"Bellou","year":"2016","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.fertnstert.2024.09.023_bib37","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ejca.2016.09.026","article-title":"Diet, body size, physical activity and risk of prostate cancer: an umbrella review of the evidence","volume":"69","author":"Markozannes","year":"2016","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.fertnstert.2024.09.023_bib38","doi-asserted-by":"crossref","first-page":"j477","DOI":"10.1136\/bmj.j477","article-title":"Adiposity and cancer at major anatomical sites: umbrella review of the literature","volume":"356","author":"Kyrgiou","year":"2017","journal-title":"Br Med J"},{"key":"10.1016\/j.fertnstert.2024.09.023_bib39","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/acps.12713","article-title":"Does psychotherapy work? An umbrella review of meta-analyses of randomized controlled trials","volume":"136","author":"Dragioti","year":"2017","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.fertnstert.2024.09.023_bib40","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1093\/humrep\/deaa293","article-title":"Fertility treatment and cancers-the eternal conundrum: a systematic review and meta-analysis","volume":"36","author":"Barcroft","year":"2021","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2024.09.023_bib41","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s10549-015-3328-0","article-title":"Breast cancer incidence after hormonal treatments for infertility: systematic review and meta-analysis of population-based studies","volume":"150","author":"Gennari","year":"2015","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.fertnstert.2024.09.023_bib42","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/IGC.0b013e318277608b","article-title":"Meta-analysis on the possible association between in\u00a0vitro fertilization and cancer risk","volume":"23","author":"Li","year":"2013","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.fertnstert.2024.09.023_bib43","first-page":"CD008215","article-title":"Risk of ovarian cancer in women treated with ovarian stimulating drugs for infertility","volume":"6","author":"Rizzuto","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.fertnstert.2024.09.023_bib44","first-page":"259","article-title":"In\u00a0vitro fertilization and breast cancer risk: a review","volume":"50","author":"Salhab","year":"2005","journal-title":"Int J Fertil Womens Med"},{"key":"10.1016\/j.fertnstert.2024.09.023_bib45","first-page":"CD010931","article-title":"Risk of endometrial cancer in women treated with ovary-stimulating drugs for subfertility","volume":"3","author":"Skalkidou","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.fertnstert.2024.09.023_bib46","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s10549-010-1140-4","article-title":"Fertility drugs and the risk of breast cancer: a meta-analysis and review","volume":"124","author":"Zreik","year":"2010","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.fertnstert.2024.09.023_bib47","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1093\/humrep\/det323","article-title":"Fertility drugs and endometrial cancer risk: results from an extended follow-up of a large infertility cohort","volume":"28","author":"Brinton","year":"2013","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2024.09.023_bib48","doi-asserted-by":"crossref","first-page":"809","DOI":"10.3109\/09513590.2012.671391","article-title":"Are infertility treatments a potential risk factor for cancer development? Perspective of 30 years of follow-up","volume":"28","author":"Lerner-Geva","year":"2012","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.fertnstert.2024.09.023_bib49","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1093\/humrep\/del411","article-title":"Tumour incidence in Swedish women who gave birth following IVF treatment","volume":"22","author":"Kristiansson","year":"2007","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2024.09.023_bib50","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1093\/humrep\/17.8.2209","article-title":"Cancer incidence following treatment for infertility at a clinic in the UK","volume":"17","author":"Doyle","year":"2002","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2024.09.023_bib51","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/S0140-6736(99)05203-4","article-title":"Risk of cancer after use of fertility drugs with in-vitro fertilisation","volume":"354","author":"Venn","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.fertnstert.2024.09.023_bib52","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1093\/oxfordjournals.aje.a009397","article-title":"Cancer incidence in a cohort of infertile women","volume":"147","author":"Modan","year":"1998","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.fertnstert.2024.09.023_bib53","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/S0015-0282(01)02986-7","article-title":"Cancer incidence in a cohort of infertile women who underwent in\u00a0vitro fertilization","volume":"77","author":"Dor","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.09.023_bib54","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1093\/humrep\/deq307","article-title":"Malignancies among women who gave birth after in\u00a0vitro fertilization","volume":"26","author":"K\u00e4ll\u00e9n","year":"2011","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2024.09.023_bib55","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1136\/ijgc-00009577-200301000-00004","article-title":"The possible association between in\u00a0vitro fertilization treatments and cancer development","volume":"13","author":"Lerner-Geva","year":"2003","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.fertnstert.2024.09.023_bib56","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1093\/humrep\/des031","article-title":"Cancer morbidity in a cohort of 9175 Finnish women treated for infertility","volume":"27","author":"Yli-Kuha","year":"2012","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2024.09.023_bib57","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1245\/s10434-007-9800-2","article-title":"The possible association between IVF and breast cancer incidence","volume":"15","author":"Pappo","year":"2008","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.fertnstert.2024.09.023_bib58","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.fertnstert.2012.04.019","article-title":"In\u00a0vitro fertilization and breast cancer: is there cause for concern?","volume":"98","author":"Stewart","year":"2012","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.09.023_bib59","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.fertnstert.2012.12.029","article-title":"In\u00a0vitro fertilization and risk of breast and gynecologic cancers: a retrospective cohort study within the Israeli Maccabi Healthcare Services","volume":"99","author":"Brinton","year":"2013","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.09.023_bib60","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1006\/gyno.1996.0002","article-title":"Risk of breast cancer in a cohort of infertile women","volume":"60","author":"Rossing","year":"1996","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.fertnstert.2024.09.023_bib61","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0015-0282(99)00085-0","article-title":"Fertility drugs and the risk of breast and ovarian cancers: results of a long-term follow-up study","volume":"71","author":"Potashnik","year":"1999","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.09.023_bib62","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1093\/humrep\/deh422","article-title":"E3N group. Breast cancer risk associated with being treated for infertility: results from the French E3N cohort study","volume":"19","author":"Gauthier","year":"2004","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2024.09.023_bib63","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1001\/archinte.166.22.2484","article-title":"A prospective study of infertility due to ovulatory disorders, ovulation induction, and incidence of breast cancer","volume":"166","author":"Terry","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.fertnstert.2024.09.023_bib64","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1158\/1055-9965.EPI-07-0075","article-title":"Risk of breast cancer after exposure to fertility drugs: results from a large Danish cohort study","volume":"16","author":"Jensen","year":"2007","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"72","key":"10.1016\/j.fertnstert.2024.09.023_bib65","first-page":"e1","article-title":"Breast cancer incidence after hormonal infertility treatment in Sweden: a cohort study","volume":"200","author":"Org\u00e9as","year":"2009","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2024.09.023_bib66","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/aje\/kwn318","article-title":"Cancer risk after exposure to treatments for ovulation induction","volume":"169","author":"Calderon-Margalit","year":"2009","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.fertnstert.2024.09.023_bib67","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1158\/1055-9965.EPI-13-0996","article-title":"Long-term relationship of ovulation-stimulating drugs to breast cancer risk","volume":"23","author":"Brinton","year":"2014","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.fertnstert.2024.09.023_bib68","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1002\/ijc.29069","article-title":"Risk of breast cancer following fertility treatment\u2014a registry based cohort study of parous women in Norway","volume":"136","author":"Reigstad","year":"2015","journal-title":"Int J Cancer"},{"key":"10.1016\/j.fertnstert.2024.09.023_bib69","doi-asserted-by":"crossref","first-page":"S74","DOI":"10.1016\/j.fertnstert.2008.07.862","article-title":"Breast cancer risk in a nation-wide cohort of 25,152 subfertile women in the Netherlands","volume":"90","author":"Van den Belt-Dusebout","year":"2008","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.09.023_bib70","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1093\/humrep\/deh371","article-title":"Breast cancer risk associated with ovulation-stimulating drugs","volume":"19","author":"Brinton","year":"2004","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2024.09.023_bib71","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S0140-6736(95)91687-3","article-title":"Breast and ovarian cancer incidence after infertility and in\u00a0vitro fertilisation","volume":"346","author":"Venn","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.fertnstert.2024.09.023_bib72","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1093\/oxfordjournals.aje.a114595","article-title":"Cancer incidence in a cohort of infertile wome","volume":"125","author":"Ron","year":"1987","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.fertnstert.2024.09.023_bib73","first-page":"437","article-title":"Treatment with human chorionic gonadotropin and risk of breast cancer","volume":"4","author":"Bernstein","year":"1995","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.fertnstert.2024.09.023_bib74","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/S0015-0282(02)04950-6","article-title":"Infertility drugs and the risk of breast cancer: findings from the National Institute of Child Health and Human Development Women\u2019s Contraceptive and Reproductive Experiences Study","volume":"79","author":"Burkman","year":"2003","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.09.023_bib75","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1093\/HUMREP\/11.2.300","article-title":"Fertility treatment and risk of breast cancer","volume":"11","author":"Braga","year":"1996","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2024.09.023_bib76","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1093\/humrep\/14.6.1653","article-title":"Fertility drugs and the risk of breast cancer","volume":"14","author":"Ricci","year":"1999","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2024.09.023_bib77","doi-asserted-by":"crossref","first-page":"3456","DOI":"10.1093\/humrep\/der322","article-title":"Risk of borderline and invasive ovarian tumours after ovarian stimulation for in\u00a0vitro fertilization in a large Dutch cohort","volume":"26","author":"van Leeuwen","year":"2011","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2024.09.023_bib78","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1093\/oxfordjournals.humrep.a138771","article-title":"Fertility drugs and risk of epithelial ovarian cancer in Italy","volume":"9","author":"Franceschi","year":"1994","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2024.09.023_bib79","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0015-0282(16)58020-0","article-title":"Human menopausal gonadotropin and the risk of epithelial ovarian cancer","volume":"65","author":"Shushan","year":"1996","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.09.023_bib80","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0015-0282(97)81431-8","article-title":"Infertility, fertility drugs, and invasive ovarian cancer: a case-control study","volume":"67","author":"Mosgaard","year":"1997","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.09.023_bib81","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1093\/humrep\/12.10.2159","article-title":"Treatment for infertility and risk of invasive epithelial ovarian cancer","volume":"12","author":"Parazzini","year":"1997","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2024.09.023_bib82","doi-asserted-by":"crossref","first-page":"b249","DOI":"10.1136\/bmj.b249","article-title":"Use of fertility drugs and risk of ovarian cancer: Danish population based cohort study","volume":"338","author":"Jensen","year":"2009","journal-title":"Br Med J"},{"key":"10.1016\/j.fertnstert.2024.09.023_bib83","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1093\/humrep\/16.7.1372","article-title":"Use of fertility drugs and risk of ovarian cancer","volume":"16","author":"Parazzini","year":"2001","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2024.09.023_bib84","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1056\/NEJM199409223311204","article-title":"Ovarian tumors in a cohort of infertile women","volume":"331","author":"Rossing","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.fertnstert.2024.09.023_bib85","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1093\/aje\/kwh315","article-title":"A case-control study of ovarian cancer in relation to infertility and the use of ovulation-inducing drugs","volume":"160","author":"Rossing","year":"2004","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.fertnstert.2024.09.023_bib86","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1038\/sj.bjc.6605086","article-title":"Ovulation-stimulation drugs and cancer risks: a long-term follow-up of a British cohort","volume":"100","author":"Silva","year":"2009","journal-title":"Br J Cancer"},{"key":"10.1016\/j.fertnstert.2024.09.023_bib87","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1158\/1055-9965.EPI-12-0426","article-title":"Use of fertility drugs and risk of ovarian cancer: results from a U.S.-based case-control study","volume":"21","author":"Kurta","year":"2012","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.fertnstert.2024.09.023_bib88","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1093\/humrep\/deu297","article-title":"Risk for borderline ovarian tumours after exposure to fertility drugs: results of a population-based cohort study","volume":"30","author":"Bj\u00f8rnholt","year":"2015","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2024.09.023_bib89","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s00432-015-2035-x","article-title":"The risk of female malignancies after fertility treatments: a cohort study with 25-year follow-up","volume":"142","author":"Kessous","year":"2016","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.fertnstert.2024.09.023_bib90","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/j.fertnstert.2015.07.1135","article-title":"Cancer in women after assisted reproductive technology","volume":"104","author":"Luke","year":"2015","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.09.023_bib91","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.fertnstert.2015.02.011","article-title":"Fertility treatments and invasive epithelial ovarian cancer risk in Jewish Israeli BRCA1 or BRCA2 mutation carriers","volume":"103","author":"Perri","year":"2015","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.09.023_bib92","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1158\/1055-9965.EPI-16-0809","article-title":"Cancer risk in women treated with fertility drugs according to parity status-a registry-based cohort study","volume":"26","author":"Reigstad","year":"2017","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.fertnstert.2024.09.023_bib93","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1093\/humrep\/dev124","article-title":"Cancer risk among parous women following assisted reproductive technology","volume":"30","author":"Reigstad","year":"2015","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2024.09.023_bib94","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.ygyno.2012.10.023","article-title":"In\u00a0vitro fertilization, endometriosis, nulliparity and ovarian cancer risk","volume":"128","author":"Stewart","year":"2013","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.fertnstert.2024.09.023_bib95","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.ygyno.2013.01.027","article-title":"In\u00a0vitro fertilization is associated with an increased risk of borderline ovarian tumours","volume":"129","author":"Stewart","year":"2013","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.fertnstert.2024.09.023_bib96","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1016\/j.fertnstert.2013.08.008","article-title":"Ovulation-inducing drugs and ovarian cancer risk: results from an extended follow-up of a large United States infertility cohort","volume":"100","author":"Trabert","year":"2013","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.09.023_bib97","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1016\/j.fertnstert.2013.02.010","article-title":"Fertility drug use and the risk of ovarian tumors in infertile women: a case-control study","volume":"99","author":"Asante","year":"2013","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.09.023_bib98","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.fertnstert.2015.11.034","article-title":"Treatment of infertility does not increase the risk of ovarian cancer among women with a BRCA1 or BRCA2 mutation","volume":"105","author":"Gronwald","year":"2016","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.09.023_bib99","series-title":"Risk of hormone-related cancers after ovarian stimulation for in-vitro fertilisation in a cohort of 25,152 women","first-page":"55","author":"Klip","year":"2002"},{"key":"10.1016\/j.fertnstert.2024.09.023_bib100","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0301-2115(01)00344-X","article-title":"Ovulation induction and risk of endometrial cancer: a pilot study","volume":"98","author":"Benshushan","year":"2001","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.fertnstert.2024.09.023_bib101","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1093\/aje\/kwp290","article-title":"Use of fertility drugs and risk of uterine cancer: results from a large Danish population-based cohort study","volume":"170","author":"Jensen","year":"2009","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.fertnstert.2024.09.023_bib102","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1136\/ijgc-00009577-200409001-00014","article-title":"Risk of hormone related cancers after ovarian stimulation for IVF in a cohort of 25,152 women","volume":"14","author":"Burger","year":"2004","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.fertnstert.2024.09.023_bib103","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1093\/humrep\/16.1.196","article-title":"Risk of endometrial cancer after use of fertility drugs","volume":"16","author":"Parazzini","year":"2001","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2024.09.023_bib104","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1097\/CEJ.0b013e32833d9388","article-title":"Use of fertility drugs and risk of endometrial cancer in an Italian case-control study","volume":"19","author":"Parazzini","year":"2010","journal-title":"Eur J Cancer Prev"},{"key":"10.1016\/j.fertnstert.2024.09.023_bib105","first-page":"1111","article-title":"Infertility, treatment of infertility, and the risk of breast cancer among women with BRCA1 and BRCA2 mutations: a case-control study","volume":"19","author":"Kotsopoulos","year":"2008","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.fertnstert.2024.09.023_bib106","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s10549-006-9238-4","article-title":"Infertility, ovulation induction treatments and the incidence of breast cancer\u2014a historical prospective cohort of Israeli women","volume":"100","author":"Lerner-Geva","year":"2006","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.fertnstert.2024.09.023_bib107","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1006\/gyno.1997.4928","article-title":"Treatment for fertility and risk of ovarian tumors of borderline malignancy","volume":"68","author":"Parazzini","year":"1998","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.fertnstert.2024.09.023_bib108","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0015-0282(98)00337-9","article-title":"Ovarian stimulation and borderline ovarian tumors: a case-control study","volume":"70","author":"Mosgaard","year":"1998","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.09.023_bib109","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.fertnstert.2017.05.010","article-title":"Ovarian stimulation and risk of breast cancer in Swedish women","volume":"108","author":"Lundberg","year":"2017","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.09.023_bib110","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1001\/jama.2016.9389","article-title":"Ovarian stimulation for in\u00a0vitro fertilization and long-term risk of breast cancer","volume":"316","author":"van den Belt-Dusebout","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.fertnstert.2024.09.023_bib111","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.clbc.2018.03.003","article-title":"Breast cancer and ovulation induction treatments","volume":"18","author":"Taheripanah","year":"2018","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.fertnstert.2024.09.023_bib112","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.fertnstert.2004.02.109","article-title":"Ovarian cancer risk associated with varying causes of infertility","volume":"82","author":"Brinton","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.09.023_bib113","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.fertnstert.2008.01.073","article-title":"Ovarian epithelial neoplasia after hormonal infertility treatment: long-term follow-up of a historical cohort in Sweden","volume":"91","author":"Sanner","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.09.023_bib114","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1007\/s10654-019-00540-3","article-title":"Assisted reproductive technology and risk of ovarian cancer and borderline tumors in parous women: a population-based cohort study","volume":"34","author":"Lundberg","year":"2019","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.fertnstert.2024.09.023_bib115","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1093\/oxfordjournals.aje.a116427","article-title":"Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women. Collaborative Ovarian Cancer Group","volume":"136","author":"Whittemore","year":"1992","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.fertnstert.2024.09.023_bib116","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1093\/aje\/kwi084","article-title":"Uterine cancer after use of clomiphene citrate to induce ovulation","volume":"161","author":"Althuis","year":"2005","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.fertnstert.2024.09.023_bib117","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0015-0282(16)58021-2","article-title":"In situ and invasive cervical carcinoma in a cohort of infertile women","volume":"65","author":"Rossing","year":"1996","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.09.023_bib118","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.ajog.2005.01.091","article-title":"Melanoma, thyroid, cervical, and colon cancer risk after use of fertility drugs","volume":"193","author":"Althuis","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2024.09.023_bib119","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.fertnstert.2021.01.044","article-title":"Risk of breast cancer in women treated with ovarian stimulation drugs for infertility: a systematic review and meta-analysis","volume":"116","author":"Beebeejaun","year":"2021","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.09.023_bib120","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0140-6736(71)92335-X","article-title":"Incessant ovulation\u2014a factor in ovarian neoplasia?","volume":"2","author":"Fathalla","year":"1971","journal-title":"Lancet"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028224022362?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028224022362?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T04:34:05Z","timestamp":1769747645000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028224022362"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":120,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S0015028224022362"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2024.09.023","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An umbrella review of meta-analyses regarding the incidence of female-specific malignancies after fertility treatment","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2024.09.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a92024 The Authors. Published by Elsevier Inc. on behalf of the American Society for Reproductive Medicine.","name":"copyright","label":"Copyright"}]}}